AstraZeneca agrees to research deal worth up to $5.22 billion with CSPC

• click to rate

  Posted by Two Blokes Jun 13 - Filed in Stock - 4 views
  
  AstraZeneca said on Friday it has agreed to a research deal with Chinese drugmaker CSPC Pharmaceuticals worth up to $5.22 billion to focus on AI-enabled initiatives.